News
May 2025 marked another key milestone for Reacta Healthcare, as the first production run of pharmaceutical grade milk and egg ...
The financing will support the ongoing interventional Phase I/II ASTRA trial and the observational POLARIS study of SB-007.
Experts say clinicians struggle for time to support clinical studies, limiting the scope of progress from regulatory revisions.
Britons have been urged to check their painkillers after batches of prescription paracetamol were recalled due to contamination fears. The Medicines and Healthcare products Regulatory Agency (MHRA) ...
SIFI, a leading international ophthalmic company, today announced that its shareholders have signed an agreement, subject to conditions precedent, to sell 100% of SIFI shares to Faes Farma, a leading ...
NetraMark Holdings Inc. (the "Company" or "NetraMark") , an artificial intelligence (AI) solutions company transforming clinical trial design in the pharmaceutical industry through streamlined access ...
I knew I had to change things. I had high blood pressure, cholesterol, heart palpitations and heavy water retention that had ...
The family of a Newry boy fighting for access to a new "life-changing" medication are now challenging the Belfast Health and ...
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the ...
The campaign ‘Insurance United Against Dementia’ has appointed Marsh McLennan UK CEO, Chris Lay, as its new chairperson.
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results